Wu K D, Hansen E R
Department of Dermatology, Marselisborg Hospital, University of Aarhus, 8000 Aarhus C, Denmark.
Exp Dermatol. 2001 Oct;10(5):329-36. doi: 10.1034/j.1600-0625.2001.100505.x.
We have recently demonstrated that telomerase activity is increased and telomere length shortened in lymphocytes from peripheral blood of patients with cutaneous T-cell lymphoma. In order to determine which cell type has increased telomerase activity and shortened telomere length, CD4+, CD8+, CLA+ CD3+ and CLA- CD3+ T cells were isolated from peripheral blood of 25 patients, including 15 patients with mycosis fungoides and 10 patients with parapsoriasis. Eleven healthy individuals were used as controls; CD19+ B cells were separated from each individual as an internal control. The results showed that the increased telomerase activity was significantly predominating in the CD4+ T-cell subset. Significantly shortened telomere length was found in CD4+ and CD8+ T-cell subsets from the patients compared with the same cell subsets obtained from healthy individuals. However, no difference was observed between the subsets; CD19+ B cells collected from patients and healthy control individuals had similar telomerase activity and telomere length which was significantly different from the values found in T cells. The telomere length was significantly shorter in CLA+ CD3+ subset than in CLA- CD3+ subset. Interestingly, increased telomerase activity and shortened telomere length was also detected in CD4+ T cells from patients with parapsoriasis indicating that alteration of telomerase activity and telomere length in CD4+ T cells is an early event in the pathogenesis of cutaneous T-cell lymphoma. Thus, the results indicate that a significant high level of telomerase activity and shortened telomere length frequently occur in T cells of patients with CTCL and may reflect tumorigenesis.
我们最近证明,皮肤T细胞淋巴瘤患者外周血淋巴细胞中的端粒酶活性增加,端粒长度缩短。为了确定哪种细胞类型的端粒酶活性增加且端粒长度缩短,从25例患者的外周血中分离出CD4 +、CD8 +、CLA + CD3 +和CLA - CD3 + T细胞,其中包括15例蕈样肉芽肿患者和10例副银屑病患者。11名健康个体作为对照;从每个个体中分离出CD19 + B细胞作为内部对照。结果显示,端粒酶活性增加在CD4 + T细胞亚群中占显著优势。与健康个体相同细胞亚群相比,患者的CD4 +和CD8 + T细胞亚群中端粒长度显著缩短。然而,各亚群之间未观察到差异;从患者和健康对照个体收集的CD19 + B细胞具有相似的端粒酶活性和端粒长度,这与T细胞中的值显著不同。CLA + CD3 +亚群中的端粒长度明显短于CLA - CD3 +亚群。有趣的是,在副银屑病患者的CD4 + T细胞中也检测到端粒酶活性增加和端粒长度缩短,这表明CD4 + T细胞中端粒酶活性和端粒长度的改变是皮肤T细胞淋巴瘤发病机制中的早期事件。因此,结果表明,CTCL患者的T细胞中经常出现显著高水平的端粒酶活性和缩短的端粒长度,这可能反映了肿瘤发生。